Gothenburg, Sweden

Per Arvid Emil Carlsson

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Arvid Emil Carlsson. Retrieved from https://idiyas.com/inventor/per-arvid-emil-carlsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2001

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Per Arvid Emil Carlsson: Innovator in Neurological and Psychiatric Treatments.

Introduction

Per Arvid Emil Carlsson is a notable inventor based in Goteborg, Sweden. He has made significant contributions to the field of neurological and psychiatric disorders through his innovative research. His work focuses on the modulation of monoaminergic neurotransmitter receptors, which are crucial for brain signaling.

Latest Patent Applications

Carlsson's latest patent application is titled "PHENYLPIPERIDINE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS." This application relates to the novel use of both enantiomers of the phenylpiperidine derivative OSU6162, specifically (−) and (+)-OSU6162, as partial agonists on 5-hydroxytryptamine (5-HT) receptors. The compounds may be utilized for the treatment and/or prevention of diseases that require modulation of these neurotransmitter receptors. This innovative approach aims to stabilize both dopaminergic and serotonergic brain signaling.

Conclusion

Per Arvid Emil Carlsson's work represents a significant advancement in the treatment of neurological and psychiatric disorders. His research on phenylpiperidine compounds showcases the potential for innovative therapies in this critical area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…